Back to Search Start Over

Adding cisplatin to split course radiotherapy increases progression-free survival compared to radiotherapy alone in people with inoperable squamous cell esophageal cancer

Authors :
D.H. Ilson
Source :
Evidence-based Oncology. 2:221-223
Publication Year :
2001
Publisher :
Elsevier BV, 2001.

Subjects

Subjects :
Oncology
Cisplatin
medicine.medical_specialty
Squamous cell esophageal cancer
business.industry
Internal medicine
medicine
Progression-free survival
Radiotherapy alone
business
Split course radiotherapy
medicine.drug

Details

ISSN :
13634054
Volume :
2
Database :
OpenAIRE
Journal :
Evidence-based Oncology
Accession number :
edsair.doi...........0cb514c48e4ea002b3837e5f7e0430ee
Full Text :
https://doi.org/10.1054/ebon.2001.0162
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details